Prostatic Neoplasms: all 6,484 studies
Page 57 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical ProstatectomyCompletedNCT00790595Phase 1
- BN83495 in Prostate CancerCompletedNCT00790374Phase 1
- Fiducial Localization and Individualized Radiotherapy -Prostate CancerCompletedNCT00789607Not applicable
- Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation TherapyTerminatedNCT00788307Phase 1
- Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN NeoplasiaCompletedNCT00780754Phase 3
- White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local TherapyCompletedNCT00779168Phase 1
- Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)CompletedNCT00777959Phase 2
- A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate CancerCompletedNCT00777452
- MRI-Guided Biopsy of Recurrent Prostate Cancer After RadiotherapyCompletedNCT00775866Not applicable
- Study of Focal Cryoablation in Low-Risk Prostate CancerCompletedNCT00774436Phase 2
- Patients Overexposed for a Prostate AdenocarcinomaCompletedNCT00773656
- SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate CancerTerminatedNCT00773318Not applicable
- Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate CancerCompletedNCT00773305
- A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)Status unknownNCT00772317Not applicable
- Radical Prostatectomy and Perioperative Fluid TherapyCompletedNCT00771966Phase 4
- Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate CancerWithdrawnNCT00771017Phase 2
- AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate CancerCompletedNCT00770848Phase 1/2
- Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate CancerStatus unknownNCT00770822Not applicable
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate CancerCompletedNCT00769795Phase 2
- Radiation Therapy and Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00769548Phase 3
- Evaluating Symptom Management Educational Materials for Patients With Prostate CancerCompletedNCT00769431Not applicable
- Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate CancerActive, not recruitingNCT00769223
- Symptom Management in African-American Men With Localized Prostate CancerWithdrawnNCT00767845
- Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00767286Phase 3
- PHA-739358 for Treatment of Hormone Refractory Prostate CancerCompletedNCT00766324Phase 2
- Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate CancerCompletedNCT00765479Phase 2/3
- CMT-07-08: The PROstate Bed Evaluation StudyCompletedNCT00763152
- Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino MenCompletedNCT00761124Not applicable
- Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00758173
- A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone MetastasesTerminatedNCT00757757Phase 1/2
- Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.CompletedNCT00757692Phase 2
- Magnetic Resonance (MR) Spectroscopy in Localized Prostate CancerCompletedNCT00756392Not applicable
- The AIM Study: Assessing the Impact of Margin ReductionCompletedNCT00754000
- Selenium in Treating Patients With Prostate CancerCompletedNCT00752739Phase 2
- An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate CancerCompletedNCT00748358Phase 2
- Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active SurveillanceCompletedNCT00744549Phase 2
- Vitamin D Effects on Prostate PathologyStatus unknownNCT00741364Phase 2
- Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate CancerCompletedNCT00739791Not applicable
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer SurvivorsCompletedNCT00738140Phase 2
- Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate CancerWithdrawnNCT00736164Phase 2
- Depiction of Prostate Cancer Treatment Alternatives in GreeceCompletedNCT00733213
- Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate CancerStatus unknownNCT00732043Phase 2
- Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate CancerStatus unknownNCT00731848Phase 2
- Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerCompletedNCT00728663Phase 2
- Open-Label, Randomised Parallel-Group StudyWithdrawnNCT00728533Phase 3
- Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate CancerCompletedNCT00723086Phase 2
- A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before ProstatectomyCompletedNCT00719030Not applicable
- Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful WaitingCompletedNCT00717613
- A Phase I/II Study of HE3235 in Patients With Prostate CancerCompletedNCT00716794Phase 1/2
- Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer PatientsTerminatedNCT00714376Phase 2
- Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging AgentsCompletedNCT00712829Phase 1
- Internet Support for Cancer PatientsCompletedNCT00710658Not applicable
- Prostate Cancer: Family Care for Patients and SpousesCompletedNCT00708968Not applicable
- Study of WST11 in Patients With Localized Prostate CancerCompletedNCT00707356Phase 2
- Phase II Study of BI 2536 in Prostate CancerCompletedNCT00706498Phase 2
- Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant AlhydrogelCompletedNCT00705835Phase 1
- Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate CancerTerminatedNCT00705822Phase 3
- Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 YearStatus unknownNCT00703768
- Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco AreaCompletedNCT00702104
- Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21CompletedNCT00698711Phase 1
- Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.CompletedNCT00695851Phase 1
- Laparoscopic Vs. Open Prostatectomy OutcomesTerminatedNCT00695773
- Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate CancerWithdrawnNCT00694291Phase 2
- Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex TherapyCompletedNCT00692874
- Personal Patient Profile Prostate (P4) Randomized, Multisite TrialCompletedNCT00692653Not applicable
- Radiotherapy for Prostate Cancer: Conventional Dose Versus High DoseCompletedNCT00692107Phase 3
- Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the ProstateWithdrawnNCT00691977Phase 1
- A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)WithdrawnNCT00691899Phase 3
- Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or NotCompletedNCT00688532
- An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation TherapyCompletedNCT00686088Phase 2
- Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone MetastasesCompletedNCT00685646Phase 3
- Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate CancerWithdrawnNCT00685633Phase 2
- Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)Status unknownNCT00684970Phase 2
- Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation TherapyCompletedNCT00684905Phase 2
- Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate CancerStatus unknownNCT00681694
- Botulinum Toxin Injection With Prostate BrachytherapyWithdrawnNCT00681148Phase 2
- Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)CompletedNCT00678054Phase 2
- Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and BiomarkersCompletedNCT00676286Phase 1
- A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) PatientsCompletedNCT00675545Phase 2
- (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate CancerCompletedNCT00673205Phase 3
- Casodex vs Placebo in Non-Metastatic Early Prostate CancerCompletedNCT00672282Phase 3
- A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2
- A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck CancerCompletedNCT00670553Phase 1
- [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes MetastasesStatus unknownNCT00670527Not applicable
- Herbal Therapy for Treatment of Recurrent Prostate CancerCompletedNCT00669656Phase 2
- Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate CancerCompletedNCT00668083
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- PK in Pts With HRPC & Skeletal MetastesCompletedNCT00667537Phase 1
- BAY88-8223, Does Response Study in HRPC PatientsCompletedNCT00667199Phase 2
- Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate CancerCompletedNCT00667069Phase 3
- Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate CancerCompletedNCT00664456Phase 3
- Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningSuspendedNCT00664196Phase 1
- A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate CancerCompletedNCT00663832Phase 1
- Development of a Clinical Trial Specific Question Prompt ListCompletedNCT00662324
- Exercise for Physical Health in Men With Prostate CancerCompletedNCT00660686Not applicable
- The Physical Exercise and Prostate Cancer StudyCompletedNCT00658229Phase 3
- Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate CancerStatus unknownNCT00657982Phase 2
- Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerCompletedNCT00657904Phase 3